Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00910689 · ClinicalTrials.gov registry record · Phase 4
Drug and Non-Drug Treatment Of Severe Migraine
A Phase 4 study, sponsored by Ohio University.
- Completed
- Registry status
- Phase 4
- Development phase
- 232
- Enrollment target
NCT00910689 is a Phase 4 study that has completed, run by Ohio University. The registered enrollment target is 232 participants.
The verdict
NCT00910689, a Phase 4 study, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 232 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the addition of preventive medication, behavior migraine management or the combination of preventive medication and behavior migraine management improves the outcome of optimal acute therapy for frequent migraines.
Interventions
- DRUG Placebo control
- DRUG Propranolol or nadolol
- BEHAVIORAL Behavioral Migraine Management (BMM)
- DRUG Optimal Acute Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2001-07 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00910689
The ClinicalTrials.gov registry entry for NCT00910689 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo control is the first listed.
NCT00910689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00910689 about?
NCT00910689 is a clinical study titled "Drug and Non-Drug Treatment Of Severe Migraine". The purpose of this study is to determine if the addition of preventive medication, behavior migraine management or the combination of preventive medication and behavior migraine management improves the outcome of optimal acute therapy for frequent migraines.
What is the current status of trial NCT00910689?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 232 participants. The study started on 2001-07. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00910689?
The interventions under investigation include: Placebo control (DRUG), Propranolol or nadolol (DRUG), Behavioral Migraine Management (BMM) (BEHAVIORAL), Optimal Acute Therapy (DRUG).
Who is sponsoring clinical trial NCT00910689?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.